Lexogen is a global leading brand in the field of transcriptomics, next-generation sequencing, RNA analysis, and bioinformatics. Established in 2007, Lexogen specializes in developing innovative kits and software for RNA sequencing (RNA-Seq). They are known for their expertise in 3' mRNA sequencing, a technology that is highly efficient, robust, and sensitive.

Lexogen offers a wide range of products and services to assist researchers in their RNA analysis. Their portfolio includes kits for whole transcriptome library preparation, small RNA sequencing, expression profiling, single-cell and low-input RNA-Seq, and metabolic RNA labeling. They also provide solutions for RNA enrichment and depletion, RNA stabilization, DNA extraction, cDNA amplification, and NGS data analysis.

In addition to their products, Lexogen offers fully integrated and customizable NGS services, ranging from experimental design consulting to tailored bioinformatics analysis and reporting. With headquarters in Vienna, Austria, and a subsidiary in New Hampshire, USA, Lexogen is dedicated to empowering customers with innovative RNA analysis solutions. Their vision is to become the go-to brand for RNA expertise, while their mission is to improve health and well-being for everyone and the planet